{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:01:12Z","timestamp":1793642472793,"version":"4.5.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K76AG083286"],"award-info":[{"award-number":["K76AG083286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10620-025-09395-z","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:04:39Z","timestamp":1758002679000},"page":"594-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Moniyka","family":"Sachar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakdee","family":"Rojanasopondist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Delau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Minerva","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan Eric","family":"Axelrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Holmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hudesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seymour","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Malter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"9395_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","volume":"156","author":"S Coward","year":"2019","unstructured":"Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A et al. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. Gastroenterology 2019;156:1345\u20131353. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.002.","journal-title":"Gastroenterology"},{"key":"9395_CR2","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","volume":"5","author":"MD Kappelman","year":"2007","unstructured":"Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ et al. The Prevalence and Geographic Distribution of Crohn\u2019s Disease and Ulcerative Colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424\u20131429. https:\/\/doi.org\/10.1016\/j.cgh.2007.07.012.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9395_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ibd.20029","volume":"13","author":"CG Loftus","year":"2007","unstructured":"Loftus CG, Loftus EV, Harmsen SW, Zinsmeister AR, Tremaine WJ, Melton JL et al. Update on the incidence and prevalence of Crohn\u02bcs disease and ulcerative colitis in Olmsted County, Minnesota, 1940\u20132000. Inflamm Bowel Dis 2007;13:254\u2013261. https:\/\/doi.org\/10.1002\/ibd.20029.","journal-title":"Inflamm Bowel Dis"},{"key":"9395_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time. Based on Systematic Review. Gastroenterology 2012;142:46\u201354. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.001.","journal-title":"Based on Systematic Review. Gastroenterology"},{"key":"9395_CR5","first-page":"415","volume":"17","author":"S Katz","year":"2021","unstructured":"Katz S, Kane SV. Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) 2021;17:415\u2013419.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"9395_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1053\/j.gastro.2022.07.062","volume":"163","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Christensen HS, B\u00f8gsted M, Colombel J-F, Jess T, Allin KH. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study. Gastroenterology 2022;163:1547\u20131554. https:\/\/doi.org\/10.1053\/j.gastro.2022.07.062.","journal-title":"Gastroenterology"},{"key":"9395_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.gastro.2017.10.034","volume":"154","author":"\u00c5H Everhov","year":"2018","unstructured":"Everhov \u00c5H, Halfvarson J, Myrelid P, Sachs MC, Nordenvall C, S\u00f6derling J et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology 2018;154:518\u2013528. https:\/\/doi.org\/10.1053\/j.gastro.2017.10.034.","journal-title":"Gastroenterology"},{"key":"9395_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/MIB.0000000000001031","volume":"23","author":"C Alexakis","year":"2017","unstructured":"Alexakis C, Saxena S, Chhaya V, Cecil E, Curcin V, Pollok R. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study. Inflamm Bowel Dis 2017;23:672\u2013680. https:\/\/doi.org\/10.1097\/MIB.0000000000001031.","journal-title":"Inflamm Bowel Dis"},{"key":"9395_CR9","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cgh.2020.02.048","volume":"18","author":"JJ Rozich","year":"2020","unstructured":"Rozich JJ, Dulai PS, Fumery M, Sandborn WJ, Singh S. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies. Clin Gastroenterol Hepatol 2020;18:2437\u20132447. https:\/\/doi.org\/10.1016\/j.cgh.2020.02.048.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9395_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","volume":"9","author":"M Cottone","year":"2011","unstructured":"Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D\u2019Inca R et al. Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2011;9:30\u201335. https:\/\/doi.org\/10.1016\/j.cgh.2010.09.026.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9395_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ibd.23026","volume":"19","author":"A Desai","year":"2013","unstructured":"Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V et al. Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2013;19:309\u2013315. https:\/\/doi.org\/10.1002\/ibd.23026.","journal-title":"Inflamm Bowel Dis"},{"key":"9395_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/apt.13294","volume":"42","author":"T Lobat\u00f3n","year":"2015","unstructured":"Lobat\u00f3n T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:441\u2013451. https:\/\/doi.org\/10.1111\/apt.13294.","journal-title":"Aliment Pharmacol Ther"},{"key":"9395_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrgastro.2013.241","volume":"11","author":"CY Ha","year":"2014","unstructured":"Ha CY, Katz S. Clinical implications of ageing for the management of IBD. Nat Rev Gastroenterol Hepatol 2014;11:128\u2013138. https:\/\/doi.org\/10.1038\/nrgastro.2013.241.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9395_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.34200","volume":"5","author":"S Singh","year":"2022","unstructured":"Singh S, Iversen AT, Allin KH, Jess T. Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases. JAMA Netw Open 2022;5:e2234200. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.34200.","journal-title":"JAMA Netw Open"},{"key":"9395_CR15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/MIB.0000000000000817","volume":"22","author":"SM Govani","year":"2016","unstructured":"Govani SM, Wiitala WL, Stidham RW, Saini SD, Hou JK, Feagins LA et al. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1923\u20131928. https:\/\/doi.org\/10.1097\/MIB.0000000000000817.","journal-title":"Inflamm Bowel Dis"},{"key":"9395_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.cgh.2018.12.032","volume":"17","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, Ananthakrishnan AN. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2019;17:1736\u20131743. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.032.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9395_CR17","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.3390\/jcm11154422","volume":"11","author":"GD Hahn","year":"2022","unstructured":"Hahn GD, Golovics PA, Wetwittayakhlang P, Santa Maria DM, Britto U, Wild GE et al. Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:4422. https:\/\/doi.org\/10.3390\/jcm11154422.","journal-title":"J Clin Med"},{"key":"9395_CR18","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1111\/bcp.14785","volume":"87","author":"W Kantasiripitak","year":"2021","unstructured":"Kantasiripitak W, Verstockt B, Alsoud D, Lobat\u00f3n T, Thomas D, Gils A, Vermeire S, Ferrante M, Dreesen E. The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases. Br J Clin Pharmacol 2021;87:3776\u20133789. https:\/\/doi.org\/10.1111\/bcp.14785. (Epub 2021 Mar 27 PMID: 33604964).","journal-title":"Br J Clin Pharmacol"},{"key":"9395_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Sch\u00f6lmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A. International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021;160:1570\u20131583. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","journal-title":"Gastroenterology"},{"key":"9395_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.13948","volume":"45","author":"L Vuitton","year":"2017","unstructured":"Vuitton L, Peyrin-Biroulet L, Colombel JF, Pariente B, Pineton de Chambrun G, Walsh AJ, Panes J, Travis SP, Mary JY, Marteau P. Defining Endoscopic Response and Remission in Ulcerative Colitis Clinical Trials: An International Consensus. Alimentary Pharmacol & Therapeutics 2017;45:801\u201313.","journal-title":"Alimentary Pharmacol & Therapeutics"},{"key":"9395_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software 2011;45:1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"Journal of Statistical Software"},{"key":"9395_CR22","doi-asserted-by":"publisher","unstructured":"Rubin, D.B. (1987) Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons Inc., New York. https:\/\/doi.org\/10.1002\/9780470316696.","DOI":"10.1002\/9780470316696"},{"key":"9395_CR23","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1016\/S2666-7568(22)00060-5","volume":"3","author":"S Vieujean","year":"2022","unstructured":"Vieujean S, Caron B, Jairath V, Benetos A, Danese S, Louis E, Peyrin-Biroulet L. Is it time to include older adults in inflammatory bowel disease trials? A call for action. Lancet Healthy Longev. 2022;3:e356\u2013e366. https:\/\/doi.org\/10.1016\/S2666-7568(22)00060-5. (Epub 2022 May 4 PMID: 36098310).","journal-title":"Lancet Healthy Longev."},{"key":"9395_CR24","first-page":"592","volume":"19","author":"E Axenfeld","year":"2023","unstructured":"Axenfeld E, Katz S, Faye AS. Management Considerations for the Older Adult With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2023;19:592\u2013599.","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"9395_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cgh.2020.04.070","volume":"19","author":"D Cheng","year":"2021","unstructured":"Cheng D, Cushing KC, Cai T, Ananthakrishnan AN. Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials. Clin Gastroenterol Hepatol. 2021;19:939\u2013946. https:\/\/doi.org\/10.1016\/j.cgh.2020.04.070. (Epub 2020 May 1 PMID: 32371165).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9395_CR26","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1007\/s10620-021-07117-9","volume":"67","author":"R Garg","year":"2022","unstructured":"Garg R, Aggarwal M, Butler R, Achkar JP, Lashner B, Philpott J, Cohen B, Qazi T, Rieder F, Regueiro M, Click B. Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn\u2019s Disease Patients. Dig Dis Sci. 2022;67:3138\u20133147.","journal-title":"Dig Dis Sci."},{"key":"9395_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/ajg.2016.236","volume":"111","author":"PS Dulai","year":"2016","unstructured":"Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn\u2019s Disease: Results From the US VICTORY Consortium. Am J Gastroenterol. 2016;111:1147\u20131155. https:\/\/doi.org\/10.1038\/ajg.2016.236. (Epub 2016 Jun 14 PMID: 27296941).","journal-title":"Am J Gastroenterol."},{"key":"9395_CR28","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41395-018-0162-0","volume":"113","author":"N Narula","year":"2018","unstructured":"Narula N, Peerani F, Meserve J, Kochhar G, Chaudrey K, Hartke J, Chilukuri P, Koliani-Pace J, Winters A, Katta L, Shmidt E. Open: Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortium. Official journal of the American College of Gastroenterology ACG. 2018;113:1345.","journal-title":"Official journal of the American College of Gastroenterology ACG."},{"key":"9395_CR29","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.14309\/ajg.0000000000001907","volume":"117","author":"D Cheng","year":"2022","unstructured":"Cheng D, Kochar B, Cai T, Ritchie CS, Ananthakrishnan AN. Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022;117:1845\u20131850.","journal-title":"Am J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09395-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:01:43Z","timestamp":1772092903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09395-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9395"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09395-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data were collected firsthand.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data transparency statement"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}]}}